NasdaqCM - Delayed Quote USD

Lixte Biotechnology Holdings, Inc. (LIXTW)

0.0388
0.0000
(0.00%)
At close: May 7 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
3,572.7890
3,572.7890
5,090.2360
6,311.4810
6,720.4450
Operating Income
-3,572.7890
-3,572.7890
-5,090.2360
-6,311.4810
-6,720.4450
Net Non Operating Interest Income Expense
-9.7730
-9.7730
1.2530
2.3200
-6.7880
Other Income Expense
-3.4030
-3.4030
1.9540
-3.3740
-1.1630
Pretax Income
-3,585.9650
-3,585.9650
-5,087.0290
-6,312.5350
-6,728.3960
Net Income Common Stockholders
-3,585.9650
-3,585.9650
-5,087.0290
-6,312.5350
-6,728.3960
Diluted NI Available to Com Stockholders
-3,585.9650
-3,585.9650
-5,087.0290
-6,312.5350
-6,728.3960
Total Operating Income as Reported
-3,572.7890
-3,572.7890
-5,090.2360
-6,311.4810
-6,720.4450
Total Expenses
3,572.7890
3,572.7890
5,090.2360
6,311.4810
6,720.4450
Net Income from Continuing & Discontinued Operation
-3,585.9650
-3,585.9650
-5,087.0290
-6,312.5350
-6,728.3960
Normalized Income
-3,582.5620
-3,582.5620
-5,088.9830
-6,309.1610
-6,727.2330
Interest Income
7.0480
7.0480
17.4860
11.1950
0.6260
Interest Expense
16.8210
16.8210
16.2330
8.8750
7.4140
Net Interest Income
-9.7730
-9.7730
1.2530
2.3200
-6.7880
EBIT
-3,569.1440
-3,569.1440
-5,070.7960
-6,303.6600
-6,720.9820
EBITDA
-3,569.1440
-3,569.1440
-5,070.7960
-6,303.6600
-6,720.9820
Net Income from Continuing Operation Net Minority Interest
-3,585.9650
-3,585.9650
-5,087.0290
-6,312.5350
-6,728.3960
Total Unusual Items Excluding Goodwill
-3.4030
-3.4030
1.9540
-3.3740
-1.1630
Total Unusual Items
-3.4030
-3.4030
1.9540
-3.3740
-1.1630
Normalized EBITDA
-3,565.7410
-3,565.7410
-5,072.7500
-6,300.2860
-6,719.8190
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RGBP Regen BioPharma, Inc.
0.0670
+15.43%
 
IBO Impact BioMedical Inc.
0.5495
+10.45%
 
JAGX Jaguar Health, Inc.
8.51
-2.13%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5272
-7.70%
 
SPRC SciSparc Ltd.
0.3443
+0.53%
 
BIVI BioVie Inc.
1.1200
-8.94%